PDT Partners’s Histogen Inc. Common Stock HSTO Stock Holding History

PDT Partners’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-478	Closed	-$680K	–	1731
2015 Q1	$680K	Buy	+478	New	+$606K	0.02%	912

Other funds holding HSTO

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

PDT Partners's HSTO Position: Q2 2015 in Review

PDT Partners sold out of Histogen Inc. Common Stock (HSTO) in Q2 2015, closing a stake of 478 shares — an estimated $680K sold.

PDT Partners first reported a position in HSTO in Q1 2015 and held it in 1 quarter. The position peaked at $680K in Q1 2015. 33 funds tracked by Wall St. Rank hold HSTO as of Q2 2015.

PDT Partners reported no remaining Histogen Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
PDT Partners sold 478 Histogen Inc. Common Stock shares in Q2 2015, an estimated $680K.
PDT Partners first reported a position in Histogen Inc. Common Stock in Q1 2015 and held it in 1 quarter.
PDT Partners's Histogen Inc. Common Stock position peaked at $680K in Q1 2015.
33 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2015.

Based on PDT Partners's 13F filing for Q2 2015, filed 14 Aug 2015.